← Back to All Filings

Medtronic Officer Files Intent to Sell $3.1M in MDT Stock

Low SignificanceNovember 19, 2025 at 11:32:08 AM EST

Medtronic plc

$MDT144CIK: 0001613103

Subscribe to track MDT

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Medtronic Officer Files Intent to Sell $3.1M in MDT Stock

Company: Medtronic plc (MDT) Form: 144 | Filed: 2025-11-19 Significance: Low

Insider: Smith Gregory L Title: Officer | Relationship: Officer

Transaction: • Type: Proposed Sale • Shares: 30,000 • Price: ~$101.95 • Value: $3,058,452 • Owned After: Not Disclosed

Key Insight: An officer has filed a notice of proposed sale for shares valued at approximately $3.1 million. The transaction size is negligible relative to Medtronic's $123B market cap.

Market Context: The sale represents a tiny fraction (0.0025%) of the company's market capitalization, indicating a routine liquidity event rather than a significant strategic move.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Medtronic plc (MDT)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer of Medtronic has filed a notice of intent to sell 30,000 shares, a transaction valued at approximately $3.1 million. The sale's size is immaterial relative to the company's market capitalization.
  • Market Impact: The transaction is unlikely to have any market impact due to its small size.

Company Information

FieldValue
CompanyMedtronic plc
Ticker SymbolMDT
CIK0001613103
IndustryElectromedical & Electrotherapeutic Apparatus

Insider Information

FieldValue
NameSmith Gregory L
CIK0001533098
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-19
Transaction CodeS (Proposed Sale)
Security TypeCommon Stock
Shares Involved30,000
Price Per Share~$101.95 (calculated)
Total Value$3,058,452.26
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$3,058,452.26
% of Market Cap0.0025%
Shares Transacted30,000
% of Shares Outstanding0.0023%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Medtronic is a mega-cap company with a market capitalization of approximately $122.96 billion. A $3.1 million transaction is financially insignificant, representing a minuscule fraction of the company's total value.
  • Transaction Significance: The sale constitutes just 0.0025% of the market cap and 0.0023% of shares outstanding, falling far below any threshold for material significance. Such sales are common for executives at large corporations for personal financial management.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is too small to signal any change in the insider's outlook or to affect market supply and demand dynamics for MDT stock.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The 30,000 shares are a tiny fraction of the typical daily trading volume for a stock of this size.
  • Sentiment Indicator: Neutral. The sale is not indicative of a bearish outlook given its small scale and the origin of the shares (ESPP and vested RSUs), which often leads to periodic sales for liquidity and diversification.

Additional Context

Transaction Notes

  • Nature of Filing: This Form 144 is a notice of a proposed sale, not a confirmation of a completed sale.
  • Source of Shares: The filing indicates the shares to be sold were acquired through an Employee Stock Purchase Plan (ESPP) and the vesting of Restricted Stock Units (RSUs), which are standard forms of executive compensation.
Topics:#SECFiling#InsiderTrading#MDT#Medtronic#Form144#InsiderSell#StockMarket#Investing#HealthcareStocks

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.